Benitec Biopharma Inc.

Contributing Author

Recent Articles by Benitec Biopharma Inc.

Nov-03	Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301 BNTC GlobeNewswire
Nov-03	Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors BNTC GlobeNewswire
Nov-02	Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy BNTC GlobeNewswire
Sep-22	Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update BNTC GlobeNewswire
Jul-09	Benitec Biopharma Provides Operational Updates BNTC GlobeNewswire
May-14	Benitec Biopharma Releases Third Quarter 2025 Financial Results BNTC GlobeNewswire